ValuEngine upgraded shares of Vitamin Shoppe, Inc (NYSE:VSI) from a hold rating to a buy rating in a research note published on Thursday.

A number of other equities research analysts have also recently commented on VSI. Goldman Sachs Group, Inc. (The) restated a sell rating and issued a $6.00 price target (down from $13.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Barclays PLC reduced their price target on shares of Vitamin Shoppe from $13.00 to $6.00 and set an equal weight rating for the company in a report on Thursday, August 10th. TheStreet cut shares of Vitamin Shoppe from a c- rating to a d rating in a report on Wednesday, August 9th. Deutsche Bank AG reiterated a hold rating and set a $7.00 price objective (down from $14.00) on shares of Vitamin Shoppe in a report on Thursday, August 10th. Finally, Morgan Stanley set a $8.00 price objective on shares of Vitamin Shoppe and gave the company a hold rating in a report on Thursday, August 10th. Four investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of $9.92.

Shares of Vitamin Shoppe (VSI) opened at 5.30 on Thursday. The company has a 50-day moving average of $5.43 and a 200 day moving average of $11.56. The company’s market capitalization is $123.08 million. Vitamin Shoppe has a 52-week low of $4.95 and a 52-week high of $28.41.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, August 9th. The specialty retailer reported $0.23 EPS for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.16). The company had revenue of $304.84 million during the quarter, compared to analyst estimates of $314.74 million. Vitamin Shoppe had a positive return on equity of 8.33% and a negative net margin of 11.98%. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.55 earnings per share. Analysts predict that Vitamin Shoppe will post $0.79 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Vitamin Shoppe, Inc (VSI) Upgraded to “Buy” at ValuEngine” was originally reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another website, it was illegally copied and republished in violation of US & international copyright & trademark law. The legal version of this news story can be read at https://www.watchlistnews.com/vitamin-shoppe-inc-vsi-upgraded-to-buy-at-valuengine/1618556.html.

In other Vitamin Shoppe news, Director John D. Bowlin acquired 40,000 shares of Vitamin Shoppe stock in a transaction dated Friday, August 25th. The stock was purchased at an average cost of $5.50 per share, for a total transaction of $220,000.00. Following the completion of the acquisition, the director now directly owns 56,028 shares of the company’s stock, valued at $308,154. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.07% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. Comerica Bank grew its holdings in shares of Vitamin Shoppe by 37.8% during the first quarter. Comerica Bank now owns 35,339 shares of the specialty retailer’s stock valued at $689,000 after buying an additional 9,685 shares during the last quarter. Aperio Group LLC acquired a new position in shares of Vitamin Shoppe during the second quarter valued at about $402,000. Teachers Advisors LLC grew its holdings in shares of Vitamin Shoppe by 4.7% during the first quarter. Teachers Advisors LLC now owns 63,691 shares of the specialty retailer’s stock valued at $1,283,000 after buying an additional 2,887 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Vitamin Shoppe by 16.7% during the second quarter. Russell Investments Group Ltd. now owns 26,788 shares of the specialty retailer’s stock valued at $312,000 after buying an additional 3,839 shares during the last quarter. Finally, First Trust Advisors LP acquired a new position in shares of Vitamin Shoppe during the first quarter valued at about $549,000. Hedge funds and other institutional investors own 96.86% of the company’s stock.

About Vitamin Shoppe

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.